Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis

Krzysztof Szymanowski 1, Mateusz Mikołajczyk 2, Przemysław Wirstlein 2, Anna Dera-Szymanowska 3
1 - Department of Mother’s and Child’s Health, Poznań University of Medical Sciences, Poland
2 - Department of Obstetrics and Gynecology, Division of Reproduction, Poznań University of Medical Sciences, Poland
3 - Department of Perinatology and Gynecology, Poznań University of Medical Sciences, Poland
Ann Agric Environ Med
2016; 23 (4):
ICID: 1226861
Article type: Original article
 
 
Introduction. The prevalence of endometriosis among reproductive age women is 7–17%; however, these figures reach 20–50% in patients suffering from infertility. Matrix metalloproteinases (MMPs) activity is thought to be particularly essential in the early phases of endometriosis development. Any changes in the equilibrium between MMPs activity and their tissue inhibitors (TIMPs) could be potentially harmful, promoting endometriosis development. The aim of this study was to investigate whether the MMP-2, MMP-9, TIMP-1 or TGF-B2 expression in eutopic endometrium from women with early endometriosis differ when compared with healthy subjects. The results were referred to the serum progesterone levels.
Materials and method. Endometrial biopsy was taken from 42 patients (18 in the study group, 22 in thecontrol group) at the time of hysteroscopy for routine histology and for RT-PCR procedures. Comparison of the quantity of gene products was performed with a programme for densitometry and compared to GADPH product, which was a reference value.
Results. The obtained results did not reveal any statistical difference in endometrial expression of MMP-2, MMp-9, TIMP-1, and TGF-β2 or serum progesterone level between women with endometriosis and without visible signs of this illness.
Conclusion. Despite the lack of statistical differences, it was observed that both examined metalloproteinases expressed a tendency to higher gene expression in the eutopic endometrium of women with endometriosis. However, both TIMP-1 and TGF-β2 expressions had the same tendency – higher values in endometriosis patients.
DOI: 10.5604/12321966.1226861
PMID 28030938 - click here to show this article in PubMed
  FULL TEXT STATS

Recommend this article to:

Name:
E-mail:
From:
Language:


Related articles in IndexCopernicus™
     tissue inhibitors of metalloproteinases [2 related records]
     matrix metalloproteinases [2 related records]
     Endometriosis [131 related records]



 

Related articles

V T.M., K M.P.,
Spurious Elevation of Ca-125 in Benign Ovarian Tum...
Background: High level of CA 125 with associated ovarian mass is highly suspicious of ovarian carcinoma but the possibility of other benign conditions with associated pelvic mass and elevated CA 125 also to be considered. Case Report: We present a ...
ABSTRACT
, ,
 LAPAROSCOPIC EVALUATION OF CHRONIC PELVIC PA...
 OBJECTIVES Chronic pelvic pain (CPP) is best defined as non-menstrual pelvic pain for at least six months, which is severe enough to cause functional disability and require medical or surgical treatment. A thorough clinical examination no do...
ABSTRACT
,
THE SERUM LEVEL OF SUPEROXIDE DISMUTASE AND THE RI...
Objective The aim of this study is to evaluate the superoxide dismutase enzyme's level and its effects, in patients with premenopausal endometriosis, on the serum levels of bone formation markers, bone resorption markers and osteoporosis. Subjects...
ABSTRACT